Sciascia Thomas

Sciascia Thomas is listed in filings as Chief Scientific Officer at Trevi Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 20, 2026, including sale activity. Recent filings connect the profile to Trevi Therapeutics, Inc. (TRVI). The current snapshot covers public activity from Aug 16, 2024 to Feb 20, 2026. Reported amounts are shown as $275 to $35.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.